Regeneron, Sanofi Announce Sarilumab Biologics License Application Accepted for Review FDA
January 08, 2016 at 04:01 AM EST
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) today announced that the U.S. Food and Drug Administration (FDA) ...
